Index
Measure ID |
Title |
eMeasure ID |
Measure Type |
NQF ID |
High Priority |
Submission Methods |
Risk Adjusted? |
Registry Measure? |
PPRNET31
|
Screening for Type 2 Diabetes
|
|
Process |
|
|
|
|
|
PPRNET32
|
Screening for albuminuria in patients at risk for CKD (DM and/or HTN)
|
|
Process |
|
|
|
|
|
PPRNET33
|
Avoiding Use of CNS Depressants in Patients on Long-Term Opioids
|
|
Process |
|
|
|
|
|
PPRNET8
|
Antiplatelet Medication for High Risk Patients
|
|
Process |
|
|
|
|
|
Q408
|
Opioid Therapy Follow-up Evaluation (Q408)
|
|
Process |
|
|
|
|
|
Q414
|
Evaluation or Interview for Risk of Opioid Misuse (Q414)
|
|
Process |
|
|
|
|
|
Q415
|
Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older
|
|
Process |
|
|
|
|
|
Q416
|
Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 Through 17 Years
|
|
Process |
|
|
|
|
|
QOPI11
|
Combination chemotherapy received within 4 months of diagnosis by women under 70 with AJCC stage IA (T1c) to III ER/PR negative breast cancer
|
|
Process |
|
|
|
|
|
QOPI15
|
GCSF administered to patients who received chemotherapy for metastatic cancer (Lower score-better)
|
|
Process |
|
|
|
|
|
QOPI5
|
Chemotherapy administered to patients with metastatic solid tumors and performance status of 3,4, or undocumented (lower score-better)
|
|
Process |
|
|
|
|
|
QUANTUM31
|
Central Line Ultrasound Guidance
|
|
Process |
|
|
|
|
|
Page 69 of 75